Natural resistance to hemopoietic allografts, in particular F1 hybrid resistance to parental grafts, represents one of the most puzzling immunological phenomena. The resistance is genetically specific, characterized by a noncodominant mode of inheritance, and major histocompatibility complex (MHC)-controlled. The effector mechanism is mediated by natural killer (NK) cells, and hence radio-resistant and preexisting. These properties are unique, and not easily reconciled with the contemporary concepts of cellular immunology and transplantation genetics. The long- term objective of this research project is to elucidate the immunogenetic, cellular, and ultimately molecular mechanisms underlying the natural resistance. This application proposes an approach towards a molecular understanding of the cell surface target structures that are recognized in F1 hybrid resistance to parental H-2b/Hh-1b hemopoietic grafts. Studies are designed primarily to test the hypothesis that the target structures for hybid resistance are oligosaccharides. Clones of lymphoma cells lacking these determinants will be selected 1) specifically by resistant F1 hybrid hosts in vivo and 2) nonspecifically in vitro by selecting variants with altered cell surface oligosaccharides. Somatic cell hybridization will be used to study the nature of genetic lesions in the variant clones. The effect of selected glycosylation inhibitors on the expression of Hh-1b determinants will be tested and Hh-1b positive and negative clones biochemically compared. These studies are essential for a better understanding of the role of NK cells in normal hemopoiesis, in immune surveillance for hemopoietic neoplasms, and in bone marrow allograft failure in man.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK013969-22
Application #
3225189
Study Section
Experimental Immunology Study Section (EI)
Project Start
1977-05-01
Project End
1992-04-30
Budget Start
1990-05-01
Budget End
1992-04-30
Support Year
22
Fiscal Year
1990
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Motoda, K; Takata, M; Kiura, K et al. (2000) SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line. Immunology 100:370-7
Dagenais, S L; Nakamura, I (1997) A physical map of the mouse H2 Bat5/Db interval. Mamm Genome 8:39-41
Zheng, W P; Kiura, K; Milisauskas, V K et al. (1996) Murine NK cell allospecificity-1 is defined by inhibitory ligands. J Immunol 156:4651-5
Zheng, W; Nakamura, I (1995) Immunological screening of homologous recombination in genes that encode surface antigens. Biotechniques 18:740-2
Zheng, W P; Kiura, K; Nakamura, I (1995) Dd is the only gene that controls NK cell resistance of heterozygous H-2b/d cells. Mol Immunol 32:773-6
Basiri, H; Kiura, K; DeNardin, E G et al. (1995) Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression. J Immunol 155:2822-32
Wroblewski, J M; Kaminsky, S G; Nakamura, I (1994) Bat-1 genes and the origin of multiple class I loci in the H-2D region. Immunogenetics 39:276-80
Milisauskas, V K; Nakamura, I (1994) The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld. Eur J Immunol 24:336-42
Kaminsky, S G; Yoshida, M A; Milisauskas, V K et al. (1992) Hemopoietic histocompatibility (Hh-1) phenotype and the regulation of its expression. Immunogenetics 35:117-25
Wroblewski, J M; Kaminsky, S G; Milisauskas, V K et al. (1990) The B144-H-2Db interval and the location of a mouse homologue of the human D6S81E locus. Immunogenetics 32:200-4

Showing the most recent 10 out of 13 publications